Proprietary data
Digitised, structured Sowa Rigpa formulas linked to plants, compounds and targets: a dataset that does not exist anywhere else.
About BBCRI
An early-stage biotech company in Thimphu, connecting Bhutan's medicinal heritage with modern science.
An early-stage biotech company in Thimphu, connecting Bhutan's medicinal heritage with modern science.
BBCRI is building Sowa-Omics™, a research platform that brings together Sowa Rigpa, Bhutanese medicinal plants, omics data and AI. The aim is to find promising therapeutic leads and test them properly.
We start from what people already use. We digitise traditional formulas, trace each ingredient to its compounds and use computational tools to link those compounds to biological targets. The strongest candidates go forward to laboratory validation with research partners.
We are a small founding team with a working prototype. Our job now is to build the data, the partnerships and the lab capacity to take this from prototype to evidence.
Sowa Rigpa holds centuries of human-use experience with medicinal formulas, yet almost none of it has been mapped to molecular targets. That is an untapped discovery pipeline. BBCRI is building the proprietary data, AI and lab partnerships to turn it into licensable leads and products.
Digitised, structured Sowa Rigpa formulas linked to plants, compounds and targets: a dataset that does not exist anywhere else.
Built around Bhutan's access and benefit-sharing framework and the Nagoya Protocol, crediting knowledge holders. Lawful access is a barrier competitors cannot easily cross.
Computation narrows thousands of candidates before any lab work, and partners run the assays. Less burn, faster answers.
Nothing is called a therapy until it is validated. That discipline is what partners, regulators and customers pay for.
We are at the very beginning, and we say so plainly. BBCRI has a small founding team and a working software prototype of the Sowa-Omics™ platform. We are registering in Gelephu Mindfulness City and are open to conversations with research partners and seed investors.
Meet the team, see what we are researching, or find out how to invest or partner.
Investors, partners and customers: tell us what you have in mind. We reply to every message.